iHerb Is Said to Select Banks for $500 Million IPO This Year
THE SO WHAT
A $500 million IPO for a vitamins‑and‑supplements e‑retailer shows public markets are still open for focused, vertical e‑commerce with clear unit economics. If you’re in a similar niche, this is a window to clean up your metrics and decide whether you’re building for strategic sale, IPO, or permanent private status.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureOaktree Capital-Backed ITG Raises $312.2 Million in US IPO
A $312.2M IPO for a digital infrastructure services firm priced below range shows public markets still want infra exposure, but are disciplined on multiples. Infra-adjacent AI and data businesses should read this as support for durable, cash-generative models over pure growth stories.
Startups & VentureThe DeepMind trio who built a poker AI are now making money for quant hedge funds
Ex‑DeepMind researchers turning poker AI chops into a $500M‑valued quant lab is another data point that top AI talent is flowing into proprietary trading, not just product startups. If you’re competing for that caliber of researcher, you need either similar upside economics or a radically different mission to stay in the game.
Startups & VentureRubenstein Doesn't See the AI Stock Bubble Bursting
When a major private equity voice says the AI bubble isn’t close to popping, it reinforces capital staying power in AI names — and pressure on operators to show real traction, not just narratives. If you’re raising on an AI story, expect investors to fund growth but scrutinize unit economics and defensibility much harder than in 2023–2024.
Startups & VentureBillion-Dollar Mix-Up Costs Korean Investors a Shot at SpaceX IPO
A billion-dollar miscommunication around SpaceX IPO access is a reminder that even sophisticated investors can lose out on core deals due to process and information gaps. If you manage strategic capital or partnerships, treat deal-flow operations—who hears what, when—as infrastructure, not ad hoc email chains.